July 2015 July 2015
Safety Related Changes
Eliquis (apixaban) is now indicated for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) in adult patients.
Eliquis (apixaban) is now indicated for the prevention of recurrent DVT and PE in adult patients.
Exelon Patch (rivastigmine) is now indicated for the treatment of patients with mild, moderate and severe dementia of the Alzheimer’s type.
Galvus (vildagliptin) is now indicated as monotherapy in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance.
Imojev (Japanese encephalitis vaccine (live, attenuated)) is now indicated for prophylaxis of Japanese encephalitis caused by the Japanese encephalitis virus, in individuals from 9 months of age and over.
Suboxone sublingual film (buprenorphine hydrochloride and naloxone hydrochloride) is now contraindicated in severe hepatic insufficiency (Child-Pugh C).
Vivaxim (Salmonella typhi Vi polysaccharide and inactivated hepatitis A virus antigen (inactivated, adsorbed) vaccine) should not be administered to anyone with a history of severe allergic reaction to any component of the vaccine; or after previous administration of the vaccine; or to a vaccine containing the same components or constituents.
Vaccination must be postponed in case of febrile or acute disease.
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au